Search

Author/Creator Van Montfort, R.

1. Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo. (October 2022)

Authors:
Harnden, A.; Huckvale, R.; Cheung, K.M.; Davis, O.; Pierrat, O.; Talbot, R.; Box, G.; Bright, M.; Akpinar, A.; Miller, D.; Hayes, A.; Gunnell, E.; Le Bihan, Y.V.; Burke, R.; Kirkin, V.; Van Montfort, R.; Raynaud, F.; Rossanese, O.; Bellenie, B.; Hoelder, S.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Investigating the effects of ERAP1 inhibition on antigen presentation and the tumour immune response. (October 2022)

Authors:
Margarido, A.; Whitton, B.; Arwert, E.; Cheeseman, M.; Kalusa, A.; Davison, G.; Salimraj, R.; Pierrat, O.; Richards, M.; dos Santos Costa, H.; Meister, P.; Hayes, A.; Reeves, E.; James, E.; Burke, R.; Raynaud, F.; Van Montfort, R.; Choudhary, J.; Rossanese, O.; Newton, G.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search